[6,7-Bis(2-methoxy-ethoxy)-quinazolin4-yl]-(3-ethynyl-phenyl)amine hydrochloride polymorph

Details for Australian Patent Application No. 2004212067 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Bubendorf, Andre Gerard; Rimmler, Goesta; Hennig, Michael; Rohrer, Franziska; Hidber, Pirmin

Agent Davies Collison Cave

Pub. Number AU-B-2004212067

PCT Pub. Number WO2004/072049

Priority 03003587.7 17.02.03 EP

Filing date 11 February 2004

Wipo publication date 26 August 2004

Acceptance publication date 19 March 2009

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 239/94 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/072049 Priority application(s): WO2004/072049

19 March 2009 Application Accepted

  Published as AU-B-2004212067

28 May 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 04 May 2009. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000

24 September 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 04 May 2009

24 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212083-Signal amplification method for detecting expressed gene

2004212064-Piperidine-benzenesulfonamide derivatives